Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide Effect on EGP in Type 1 Diabetes
NCT02408705Phase 2Completed
- Sponsor
- Medical University of Graz
- Start
- Jan 2015
- Primary completion
- May 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of liraglutide in type 1 diabetes mellitus (T1D), sponsored by Medical University of Graz. Started Jan 2015; status: completed.
02
Drugs
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02408705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02408705.